They're either jumping the gun all over the place, or have some insight into the results. New CFO, Chime trial, Oncology Europe, Gibbs looking forward to educating the Oncology community of the benefits of HA.
Alchemia Oncology Europe, page-3
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable